Filing Details

Accession Number:
0001104659-24-125093
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-12-03 16:30:17
Reporting Period:
2024-12-02
Accepted Time:
2024-12-03 16:30:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1644963 Avenue Therapeutics Inc. ATXI () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1298246 Neil Herskowitz C/O Avenue Therapeutics, Inc.
1111 Kane Concourse Suite 301
Bay Harbor Islands FL 33154
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, Par Value $0.0001 Disposition 2024-12-02 23 $2.00 97 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Effective April 26, 2024, the Issuer effected a one-for-seventy-five reverse stock split of its common stock (the "Reverse Stock Split") and the amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split.